Profile data is unavailable for this security.
About the company
GuangYuYuan Chinese Herbal Medicine Co., Ltd. is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicine and health wine. The Company's products types consist of traditional Chinese medicine, fine Chinese medicine and health wine, which include Dingkun Dan, Guilingji, Angong Niuhuang Pills and Niuhuang Qingxin Pills, among others. The Company distributes its products in domestic market.
- Revenue in CNY (TTM)1.24bn
- Net income in CNY136.56m
- Incorporated1996
- Employees1.81k
- LocationGuangYuYuan Chinese Herbal Medicine Co Ltd6F, Tower A, Liren Technology ParkNo. 52 High-Tech RoadHigh-Tech ZoneTAIYUAN 030000ChinaCHN
- Phone+86 3 517099061
- Fax+86 3 517099130
- Websitehttps://www.guangyuyuan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurisco Pharmaceutical Co Ltd | 1.43bn | 340.67m | 9.00bn | 1.52k | 27.26 | 3.97 | -- | 6.30 | 0.8124 | 0.8124 | 3.40 | 5.58 | 0.4716 | 1.14 | 4.72 | 939,069.60 | 11.23 | 12.40 | 13.35 | 14.33 | 57.16 | 51.26 | 23.81 | 23.05 | 2.82 | -- | 0.3049 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
| Nanjing Vazyme Biotech Co Ltd | 1.40bn | 23.59m | 9.35bn | 2.70k | 379.98 | 2.34 | -- | 6.67 | 0.0615 | 0.0615 | 3.84 | 9.97 | 0.2644 | 1.06 | 3.57 | 519,483.10 | 0.4122 | 13.16 | 0.5237 | 15.92 | 70.21 | 70.50 | 1.56 | 23.92 | 4.17 | -- | 0.1436 | 32.20 | -63.97 | 49.74 | -111.94 | -- | 48.61 | -- |
| Shenzhen Chipscreen Biosciences Co Ltd | 656.24m | -70.33m | 9.40bn | 1.06k | -- | 5.72 | -- | 14.32 | -0.1709 | -0.1709 | 1.60 | 4.03 | 0.2022 | 2.34 | 4.47 | 620,847.90 | -2.17 | 1.32 | -2.44 | 1.54 | 86.24 | 93.29 | -10.72 | 6.97 | 2.76 | -0.5584 | 0.441 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.86bn | -24.94m | 9.42bn | 2.89k | -- | 1.45 | -- | 3.30 | -0.0074 | -0.0074 | 0.8379 | 1.89 | 0.2476 | 2.17 | 4.52 | 990,180.10 | -0.3138 | 2.26 | -0.4836 | 3.38 | 42.33 | 72.05 | -1.27 | 7.27 | 2.39 | -- | 0.1767 | 45.67 | 14.10 | -1.26 | 6.69 | -32.76 | -4.56 | -30.12 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.24bn | 136.56m | 9.60bn | 1.81k | 70.33 | 6.13 | -- | 7.75 | 0.279 | 0.279 | 2.53 | 3.20 | 0.5011 | 0.5647 | 2.60 | 684,557.40 | 6.04 | -2.10 | 8.71 | -3.16 | 72.21 | 69.74 | 12.05 | -6.00 | 0.9873 | 21.00 | 0.0267 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
| Cansino Biologics Inc | 748.53m | -720.11m | 9.77bn | 1.49k | -- | 2.73 | -- | 13.06 | -2.92 | -2.92 | 3.03 | 20.46 | 0.0851 | 0.6341 | 1.12 | 501,023.80 | -8.41 | -4.27 | -11.09 | -5.59 | 67.71 | 41.73 | -98.82 | -27.60 | 2.27 | -8.75 | 0.2934 | -- | -65.49 | 163.48 | -63.04 | -- | 30.60 | -- |
| North China Pharmaceutical Co Ltd | 9.71bn | 79.38m | 9.83bn | 10.16k | 123.15 | 1.83 | -- | 1.01 | 0.0465 | 0.0465 | 5.68 | 3.13 | 0.4492 | 2.67 | 4.34 | 955,385.00 | 0.6731 | -0.2978 | 1.54 | -0.7042 | 29.79 | 35.73 | 1.50 | -0.5985 | 0.5609 | 1.64 | 0.6482 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
| Youcare Pharmaceutical Group Co Ltd | 4.23bn | 242.25m | 10.01bn | 3.18k | 41.33 | 2.73 | -- | 2.37 | 0.5382 | 0.5382 | 9.39 | 8.14 | 0.7221 | 2.33 | 5.37 | 1,330,727.00 | 4.11 | 7.11 | 6.04 | 11.65 | 58.62 | 64.14 | 5.70 | 8.07 | 1.52 | 105.13 | 0.1939 | 60.95 | -7.61 | 1.05 | -44.84 | -7.16 | 23.40 | -- |
| Harbin Pharmaceutical Group Co., Ltd. | 16.22bn | 613.05m | 10.05bn | 9.85k | 16.50 | 1.93 | -- | 0.6196 | 0.2418 | 0.2418 | 6.38 | 2.07 | 1.15 | 6.29 | 3.47 | 1,646,115.00 | 4.78 | 0.7414 | 12.56 | 1.89 | 27.60 | 23.87 | 4.15 | 0.7294 | 1.11 | 36.80 | 0.3633 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 9.55bn | -34.96m | 10.13bn | 8.06k | -- | 1.23 | -- | 1.06 | -0.0412 | -0.0412 | 8.20 | 6.83 | 0.555 | 3.23 | 4.28 | 1,184,162.00 | -0.3467 | 1.95 | -0.5663 | 3.77 | 39.08 | 40.58 | -0.6248 | 3.43 | 0.6491 | -- | 0.3696 | 26.07 | -13.82 | 0.3618 | -119.05 | -- | -31.58 | -- |
Data as of Nov 05 2024. Currency figures normalised to GuangYuYuan Chinese Herbal Medicine Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 2.19m | 0.45% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 2.11m | 0.43% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.30m | 0.26% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.27m | 0.26% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 767.69k | 0.16% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 540.32k | 0.11% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 204.10k | 0.04% |
| China Europe Fund Management Co., Ltd.as of 30 Jun 2024 | 166.60k | 0.03% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 111.53k | 0.02% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 74.10k | 0.02% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
